IDYA
IDEAYA Biosciences·NASDAQ
--
--(--)
--
--(--)
IDYA fundamentals
IDEAYA Biosciences (IDYA) released its earnings on Aug 5, 2025: revenue was 0 (YoY --), missed estimates; EPS was -0.88 (YoY -29.41%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.88
-29.41%
Report date
Aug 5, 2025
Earnings Call
6:00 AM on Aug 5, 2025
Meeting link.EPS
Actual | -0.59 | -0.59 | -0.17 | -0.18 | -0.28 | -0.33 | -0.31 | -0.47 | -0.36 | -0.57 | 0.04 | -0.5 | -0.49 | -0.5 | -0.46 | -0.52 | -0.53 | -0.68 | -0.6 | -1.49 | -0.82 | -0.88 | |||
Forecast | -0.575 | 1.8272 | 2.9275 | -0.2994 | -0.2969 | -0.07 | -0.3026 | -0.3112 | -0.4113 | -0.5051 | -0.6061 | -0.555 | -0.5414 | -0.5518 | -0.4891 | -0.4677 | -0.5151 | -0.5356 | -0.6477 | -0.6288 | -0.6611 | -0.7818 | |||
Surprise | 0.00% | 0.00% | 0.00% | -2.61% | -132.29% | -105.81% | +39.88% | +5.69% | -371.43% | -2.45% | -51.03% | +12.47% | -12.85% | +106.60% | +9.91% | +9.49% | +9.39% | +5.95% | -11.18% | -2.89% | -26.96% | +7.36% | -136.96% | -24.04% | -12.56% |
Revenue
Actual | -- | -- | -- | 0 | 0 | 8.97M | 10.57M | 7.25M | 8.76M | 8.98M | 2.96M | 11.36M | 5.85M | 29.70M | 4.02M | 7.88M | 3.54M | 8.04M | 3.92M | 0 | 0 | 0 | 7.00M | 0 | 0 |
Forecast | -- | -- | -- | 0 | 100.00M | 70.56M | 7.92M | 7.48M | 14.24M | 8.55M | 8.98M | 6.71M | 7.69M | 6.64M | 7.00M | 6.14M | 4.89M | 8.38M | 8.84M | 5.43M | 4.46M | 4.27M | 5.09M | 2.15M | 4.19M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | -87.29% | +33.39% | -3.13% | -38.53% | +4.98% | -67.00% | +69.31% | -23.95% | +347.15% | -42.54% | +28.28% | -27.55% | -4.08% | -55.64% | -100.00% | -100.00% | -100.00% | +37.50% | -100.00% | -100.00% |
Earnings Call
You can ask Aime
What does IDEAYA Biosciences do and what are its main business segments?What is IDEAYA Biosciences's latest dividend and current dividend yield?What is the revenue and EPS growth rate for IDEAYA Biosciences year over year?What is IDEAYA Biosciences's gross profit margin?What were the key takeaways from IDEAYA Biosciences's earnings call?What guidance did IDEAYA Biosciences's management provide for the next earnings period?What were the key takeaways from IDEAYA Biosciences’s earnings call?Did IDEAYA Biosciences beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
